Xiumei Liang

Epidemiological Characteristics of Primary Liver Cancer in Mainland China From 2003 to 2020: A Representative Multicenter Study

Jiansheng Lin, Hongwei Zhang, Hongping Yu et al. · Frontiers in Oncology · 2022 · 66 citations · Full text

Medicine, Oncology, Surgery +16

Lenvatinib with or without immune checkpoint inhibitors for patients with unresectable hepatocellular carcinoma in real-world clinical practice

Kang Chen, Wei Wei, Lei Liu et al. · Cancer Immunology Immunotherapy · 2021 · 39 citations · Full text

Medicine, Oncology, Pharmacology +16

Clinical significance of miR-1180-3p in hepatocellular carcinoma: a study based on bioinformatics analysis and RT-qPCR validation

Zihan Zhou, Xianguo Zhou, Yanji Jiang et al. · Scientific Reports · 2020 · 34 citations · Full text

Medicine, Bioinformatics, Oncology +17

Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study

Le Li, Pei‐Sheng Wu, Xiumei Liang et al. · Journal of Gastroenterology · 2023 · 33 citations

Life Sciences, Immunology, Oncology +17

Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages

Da-Long Yang, Lin Ye, Fan-Jian Zeng et al. · Hepatology · 2025 · 24 citations

Medicine, Oncology, Immunotherapy +16